Creo Medical Group (LSE:CREO) Additional Paid-In Capital : £180.90 Mil(As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Additional Paid-In Capital?

Creo Medical Group's quarterly additional paid-in capital increased from Dec. 2022 (£149.50 Mil) to Jun. 2023 (£180.90 Mil) but then stayed the same from Jun. 2023 (£180.90 Mil) to Dec. 2023 (£180.90 Mil).

Creo Medical Group's annual additional paid-in capital increased from Dec. 2021 (£149.45 Mil) to Dec. 2022 (£149.50 Mil) and increased from Dec. 2022 (£149.50 Mil) to Dec. 2023 (£180.90 Mil).

Creo Medical Group Additional Paid-In Capital Historical Data

The historical data trend for Creo Medical Group's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Additional Paid-In Capital Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

115.11

115.26

149.45

149.50

180.90

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial												149.45	149.45	149.50	180.90	180.90

Creo Medical Group Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Creo Medical Group Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (LSE:CREO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines